PHIO Q3 2022 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-28.33

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$103,000

Balance Sheet

Total Assets

$16M

Total Liabilities

$2M

Stockholders' Equity

$14M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$3M	+6.2%
Operating Income	-$4M	-$4M	+4.5%
Net Income	-$4M	-$4M	+4.4%